Bovine Serum Market size was valued at USD 800.0 million in 2021 and is projected to reach around USD 1,290.0 million in 2030 exhibiting a CAGR of 5.0% in the forecasted period.
The fast pace growth in culture media consumption in emerging countries across the globe is among the vital factors increasing the growth and demand of bovine serum market. Additionally, the increasing requirement from conventional users of serum is also contributing to the growth in the global market over the forecasted period. Furthermore, the increasing number of contract research organizations along with high advancement in biopharmaceuticals and funding offered from the government are also increasing the growth of the market. Similarly, the rising R&D activities towards the introduction of novel biopharmaceuticals is expected to impact the demand of bovine serum hence lifting the market growth in the afore mentioned forecast period. The quick advancement in research and academic initiatives by the several private and governmental sector will more fasten the expansion of the bovine serum market and are also are proposing significant growth opportunities for the market in the forecast period.
Key Companies Insights
Key players are aiming on their technological partnerships, collaborations, and merger & acquisitions policies to gain a competitive edge and expand their product portfolio & business footmark. The ongoing COVID-19 pandemic hindered the healthcare systems worldwide and driven market players to update products for unexploited prospects.
Some of the key players operating in the global bovine serum market include:
- Danaher (Cytiva)
- Merck KGaA (Sigma Aldrich)
- HiMedia Laboratories Pvt. Ltd
- Bio-Techne
- Sera Scandia (Biowest)
- Sartorius (Biological Industries)
- Atlas Biologicals
- Rocky Mountain Biologicals
- PAN-Biotech
- Thermo Fisher Scientific Inc.
- Other players
Fill Out Details to Receive FREE Sample Report Copy Here: https://analyticsmarketresearch.com/sample-request/bovine-serum-market/1966/
Some of the Recent Developments:
- In April 2021, Thermo Fisher Scientific Inc. and PPD Inc. entered into a definitive agreement in which Thermo Fisher will acquire PPD for USD 17.4 billion.
- In March 2021, Merck KgAA expanded the single-use assembly production unit at its Life Science Center in Molsheim, France.
Segments
By Product
- Charcoal Stripped
- Chromatographic
- Dialyzed Fetal Bovine Serum
- Exosome Depleted
- Stem Cell
- Other Products
By Application
- Biopharmaceuticals
- Human and Animal Vaccine
- Others
By End User
- Biotechnology & Pharmaceutical Industries
- Academic Institutes
- Others
Reasons to Purchase this Report
- Market segmentation based on qualitative and quantitative analysis, taking into account both economic and non-economic aspects.
- Data on market value (in US dollars) for each section and sub-segment
- Identifies the area and market segment anticipated to experience the quickest growth and hold the majority of the market.
- Analysis by geography showcasing product/service usage in the region and highlighting the market dynamics affecting each region.
- A competitive landscape that takes into account recent service/product launches, collaborations, company expansions, and acquisitions by the companies profiled, as well as the market share of the leading players.
- Comprehensive company profiles for the top players in the industry, including business overviews, corporate insights, product benchmarking, and SWOT analyses
- The industry’s future market forecast in light of recent changes, including growth possibilities, drivers of growth, and obstacles present in both developing and emerging economies.
- Comprises a thorough examination of the market from a number of angles using Porter’s Five Forces analysis.
- Offers market knowledge across the Value Chain
- The current market dynamics scenario and future market expansion prospects
- Post-sales analyst assistance for six months